Institutional investors increased stakes in Merck & Co. during Q4, with Good Life Advisors LLC purchasing additional shares; Merck reported Q4 EPS of $0.03, exceeding estimates by $0.12.

Institutional investors increased their stakes in Merck & Co. during Q4, with Good Life Advisors LLC purchasing an additional 1,993 shares. Merck reported Q4 earnings of $0.03 EPS, surpassing analysts' consensus estimates of ($0.09) by $0.12, and had revenue of $14.63 billion. Institutional investors currently own 76.07% of the company's stock. Several other large investors, including Ruedi Wealth Management Inc., TFO Wealth Partners LLC, and Ameliora Wealth Management Ltd, also made changes to their positions in MRK.